ARS Pharmaceuticals SPRY
NASDAQ SPRY
$4.40 +0.27 (+6.54%)
At close: Sep 29, 2026 · 4:00 PM EDT

ARS Pharmaceuticals (SPRY) Current Assets (2020 - 2026)

Updated

ARS Pharmaceuticals (SPRY) reported Current Assets of $211.51 million for Q2 2026, down 24.8% from $281.44 million a year earlier and down 13.8% from the prior quarter.

Analysis

ARS Pharmaceuticals (SPRY) Current Assets (2020 - 2026) Analysis & Trends

At the end of FY2025, ARS Pharmaceuticals posted Current Assets of $284.9 million, down 14.8% from FY2024.

  • Current Assets has a five-year compound annual growth rate of -6.1% (FY2020 to FY2025).
  • By year, Current Assets came in at $334.3 million in FY2024 (+44.3%), $231.73 million in FY2023 (-16.6%), $277.7 million in FY2022 (+357.3%) and $60.73 million in FY2021 (-84.5%).
  • The Q2 2026 figure ranks as the lowest quarterly Current Assets since Q3 2024.
  • Year over year, Current Assets has now declined in each of the last three quarters, with growth averaging 11.9% over the last eight quarters.
  • The high point for year-over-year Current Assets in five years was Q4 2022 (growth of 357.3%); the low point was Q4 2021 (a decline of 84.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $245.24 million (Q1 2026), $284.9 million (Q4 2025) and $338.86 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 ARS Pharmaceuticals 410.68 Mn 266.88 Mn 20.81 Mn 211.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 211.51 Mn
Mar 31, 2026 245.24 Mn
Dec 31, 2025 284.90 Mn
Sep 30, 2025 338.86 Mn
Jun 30, 2025 281.44 Mn
Mar 31, 2025 303.86 Mn
Dec 31, 2024 334.30 Mn
Sep 30, 2024 208.79 Mn
Jun 30, 2024 220.74 Mn
Mar 31, 2024 226.24 Mn
Dec 31, 2023 231.73 Mn
Sep 30, 2023 244.47 Mn
Jun 30, 2023 255.03 Mn
Mar 31, 2023 267.35 Mn
Dec 31, 2022 277.70 Mn
Sep 30, 2022 270.80 Mn
Jun 30, 2022 263.13 Mn
Mar 31, 2022 261.33 Mn
Dec 31, 2021 60.73 Mn
Sep 30, 2021 305.36 Mn
API Access

ARS Pharmaceuticals Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=SPRY&period=max&api_key=YOUR_API_KEY